Annovis Bio announces new publication in peer-reviewed journal

Annovis Bio announced the publication of a new article focused on the comparison of pharmacokinetic profiles of Posiphen across different species in a peer-reviewed journal Biomolecules as part of the Special Issue: Role of Amyloid Protein in Neurological Diseases. “This publication is a testament to many years of research at Annovis. While we have conducted numerous studies to advance our Posiphen pipeline, this is the first systematic and comprehensive comparison in multiple animal and human samples,” says Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis. “Consolidating all this data into one publication offers a more holistic view of Posiphen, enhancing our understanding of its mechanisms.”